Burning Rock Biotech (BNR) Debt to Equity (2021)
Burning Rock Biotech has reported Debt to Equity over the past 1 years, most recently at $0.0 for Q4 2021.
- Quarterly results put Debt to Equity at $0.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $0.0 (changed N/A YoY), and the annual figure for FY2021 was $0.0, changed.
- Debt to Equity for Q4 2021 was $0.0 at Burning Rock Biotech.
- Over the last five years, Debt to Equity for BNR hit a ceiling of $0.0 in Q4 2021 and a floor of $0.0 in Q4 2021.